# AnnotationID, ClassType, DocCharOnset(incl), DocCharOffset(excl), Text, Meta, Instances
86, Journal, 0, 13, "Diabetes Care", "", "<http://ctro/data#Publication_41482> <http://ctro/data#hasJournal> \"Diabetes Care\"."
1, PublicationYear, 16, 20, "2013", "", "<http://ctro/data#Publication_41482> <http://ctro/data#hasPublicationYear> \"2013\"."
6, Title, 101, 228, "Effects of metformin versus glipizide on cardiovascular outcomes in patients with type 2 diabetes and coronary artery disease .", "", "<http://ctro/data#Publication_41482> <http://ctro/data#hasTitle> \"Effects of metformin versus glipizide on cardiovascular outcomes in patients with type 2 diabetes and coronary artery disease .\"."
2, Metformin, 112, 121, "metformin", "", 
3, Glipizide, 129, 138, "glipizide", "", 
5, Precondition, 169, 226, "patients with type 2 diabetes and coronary artery disease", "", "<http://ctro/data#Population_41505> <http://ctro/data#hasPrecondition> \"patients with type 2 diabetes and coronary artery disease\"."
4, Type2Diabetes, 183, 198, "type 2 diabetes", "", "<http://ctro/data#ClinicalTrial_41489> <http://ctro/data#analysesHealthCondition> <http://ctro/data#Type2Diabetes>."
7, Author, 229, 235, "Hong J", "", "<http://ctro/data#Publication_41482> <http://ctro/data#hasAuthor> \"Hong J\"."
8, Author, 244, 251, "Zhang Y", "", "<http://ctro/data#Publication_41482> <http://ctro/data#hasAuthor> \"Zhang Y\"."
9, Author, 254, 259, "Lai S", "", "<http://ctro/data#Publication_41482> <http://ctro/data#hasAuthor> \"Lai S\"."
10, Author, 262, 266, "Lv A", "", "<http://ctro/data#Publication_41482> <http://ctro/data#hasAuthor> \"Lv A\"."
11, Author, 269, 273, "Su Q", "", "<http://ctro/data#Publication_41482> <http://ctro/data#hasAuthor> \"Su Q\"."
12, Author, 276, 282, "Dong Y", "", "<http://ctro/data#Publication_41482> <http://ctro/data#hasAuthor> \"Dong Y\"."
13, Author, 285, 291, "Zhou Z", "", "<http://ctro/data#Publication_41482> <http://ctro/data#hasAuthor> \"Zhou Z\"."
14, Author, 294, 300, "Tang W", "", "<http://ctro/data#Publication_41482> <http://ctro/data#hasAuthor> \"Tang W\"."
15, Author, 303, 309, "Zhao J", "", "<http://ctro/data#Publication_41482> <http://ctro/data#hasAuthor> \"Zhao J\"."
16, Author, 312, 317, "Cui L", "", "<http://ctro/data#Publication_41482> <http://ctro/data#hasAuthor> \"Cui L\"."
17, Author, 320, 325, "Zou D", "", "<http://ctro/data#Publication_41482> <http://ctro/data#hasAuthor> \"Zou D\"."
18, Author, 328, 334, "Wang D", "", 
19, Author, 337, 341, "Li H", "", "<http://ctro/data#Publication_41482> <http://ctro/data#hasAuthor> \"Li H\"."
20, Author, 344, 349, "Liu C", "", "<http://ctro/data#Publication_41482> <http://ctro/data#hasAuthor> \"Liu C\"."
21, Author, 352, 356, "Wu G", "", "<http://ctro/data#Publication_41482> <http://ctro/data#hasAuthor> \"Wu G\"."
22, Author, 359, 365, "Shen J", "", "<http://ctro/data#Publication_41482> <http://ctro/data#hasAuthor> \"Shen J\"."
23, Author, 368, 373, "Zhu D", "", "<http://ctro/data#Publication_41482> <http://ctro/data#hasAuthor> \"Zhu D\"."
26, Author, 376, 382, "Wang W", "", "<http://ctro/data#Publication_41482> <http://ctro/data#hasAuthor> \"Wang W\"."
25, Author, 385, 391, "Shen W", "", "<http://ctro/data#Publication_41482> <http://ctro/data#hasAuthor> \"Shen W\"."
24, Author, 394, 400, "Ning G", "", "<http://ctro/data#Publication_41482> <http://ctro/data#hasAuthor> \"Ning G\"."
85, China, 1035, 1040, "China", "", 
120, ObjectiveDescription, 1200, 1366, "The two major classes of antidiabetic drugs , sulfonylureas and metformin , may differentially affect macrovascular complications and mortality in diabetic patients .", "", "<http://ctro/data#ClinicalTrial_41489> <http://ctro/data#hasObjectiveDescription> \"The two major classes of antidiabetic drugs , sulfonylureas and metformin , may differentially affect macrovascular complications and mortality in diabetic patients .\"."
27, Sulfonylureas, 1246, 1259, "sulfonylureas", "", 
28, Metformin, 1264, 1273, "metformin", "", 
34, ObjectiveDescription, 1367, 1547, "We compared the long - term effects of glipizide and metformin on the major cardiovascular events in type 2 diabetic patients who had a history of coronary artery disease ( CAD ) .", "", "<http://ctro/data#ClinicalTrial_41489> <http://ctro/data#hasObjectiveDescription> \"We compared the long - term effects of glipizide and metformin on the major cardiovascular events in type 2 diabetic patients who had a history of coronary artery disease ( CAD ) .\"."
30, Glipizide, 1406, 1415, "glipizide", "", 
31, Metformin, 1420, 1429, "metformin", "", 
32, Type2Diabetes, 1468, 1483, "type 2 diabetic", "", 
33, Precondition, 1468, 1545, "type 2 diabetic patients who had a history of coronary artery disease ( CAD )", "", "<http://ctro/data#Population_41505> <http://ctro/data#hasPrecondition> \"type 2 diabetic patients who had a history of coronary artery disease ( CAD )\"."
35, Multicenter, 1594, 1605, "multicenter", "", "<http://ctro/data#ClinicalTrial_41489> <http://ctro/data#hasCTDesign> <http://ctro/data#Multicenter>."
36, Randomized, 1608, 1618, "randomized", "", "<http://ctro/data#ClinicalTrial_41489> <http://ctro/data#hasCTDesign> <http://ctro/data#Randomized>."
37, DoubleBlind, 1621, 1635, "double - blind", "", "<http://ctro/data#ClinicalTrial_41489> <http://ctro/data#hasCTDesign> <http://ctro/data#DoubleBlind>."
38, Placebo, 1638, 1645, "placebo", "", 
39, NumberPatientsCT, 1687, 1690, "304", "", "<http://ctro/data#ClinicalTrial_41489> <http://ctro/data#hasNumberPatientsCT> \"304\"."
40, Type2Diabetes, 1691, 1706, "type 2 diabetic", "", 
41, Precondition, 1691, 1724, "type 2 diabetic patients with CAD", "", "<http://ctro/data#Population_41505> <http://ctro/data#hasPrecondition> \"type 2 diabetic patients with CAD\"."
42, AvgAge, 1738, 1744, "63 . 3", "", "<http://ctro/data#Population_41505> <http://ctro/data#hasAvgAge> \"63 . 3\"."
43, MinAge, 1761, 1763, "36", "", "<http://ctro/data#Population_41505> <http://ctro/data#hasMinAge> \"36\"."
44, MaxAge, 1766, 1768, "80", "", "<http://ctro/data#Population_41505> <http://ctro/data#hasMaxAge> \"80\"."
45, Randomized, 1813, 1821, "randomly", "", 
46, Glipizide, 1849, 1858, "glipizide", "", "<http://ctro/data#Medication_41543> <http://ctro/data#hasDrug> <http://ctro/data#Glipizide>."
48, DoseValue, 1861, 1863, "30", "", "<http://ctro/data#Medication_41543> <http://ctro/data#hasDoseValue> \"30\"."
50, mg, 1864, 1866, "mg", "", "<http://ctro/data#Medication_41543> <http://ctro/data#hasDoseUnit> <http://ctro/data#mg>."
51, Frequency, 1867, 1872, "daily", "", "<http://ctro/data#Intervention_41531> <http://ctro/data#hasFrequency> \"daily\"."
47, Metformin, 1878, 1887, "metformin", "", "<http://ctro/data#Medication_41550> <http://ctro/data#hasDrug> <http://ctro/data#Metformin>."
49, DoseValue, 1890, 1895, "1 . 5", "", "<http://ctro/data#Medication_41550> <http://ctro/data#hasDoseValue> \"1 . 5\"."
53, Gram, 1896, 1897, "g", "", "<http://ctro/data#Intervention_41537> <http://ctro/data#hasFrequency> \"daily\"."
52, Frequency, 1898, 1903, "daily", "", "<http://ctro/data#Intervention_41537> <http://ctro/data#hasFrequency> \"daily\"."
54, Duration, 1910, 1917, "3 years", "", "<http://ctro/data#ClinicalTrial_41489> <http://ctro/data#hasCTduration> \"3 years\"."
55, EndPointDescription, 1948, 2005, "times to the composite of recurrent cardiovascular events", "", "<http://ctro/data#EndPointDescription_41648> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://ctro/data#EndPointDescription>. <http://ctro/data#Endpoint_41647> <http://ctro/data#hasEndoPointDescription> <http://ctro/data#EndPointDescription_41648>."
59, ObservedResult, 2247, 2255, "decrease", "", 
56, HbA1c, 2272, 2291, "glycated hemoglobin", "", "<http://ctro/data#Endpoint_41583> <http://ctro/data#hasEndoPointDescription> <http://ctro/data#HbA1c>."
65071, Reduction, 2294, 2299, "7 . 1", "", "<http://ctro/data#Outcome_41588> <http://ctro/data#hasChangeValue> \"7 . 1\"."
60, Percentage, 2300, 2301, "%", "", "<http://ctro/data#Endpoint_41583> <http://ctro/data#hasBaselineUnit> <http://ctro/data#Percentage>."
62, Glipizide, 2309, 2318, "glipizide", "", 
65077, Reduction, 2329, 2334, "7 . 0", "", "<http://ctro/data#Outcome_41615> <http://ctro/data#hasChangeValue> \"7 . 0\"."
61, Percentage, 2335, 2336, "%", "", 
65, Metformin, 2344, 2353, "metformin", "", 
147, TimePoint, 2391, 2402, "5 . 0 years", "", 
69, NumberAffected, 2405, 2407, "91", "", 
71, ObservedResult, 2421, 2457, "had developed 103 primary end points", "", 
72, IntentionToTreat, 2460, 2491, "Intention - to - treat analysis", "", "<http://ctro/data#ClinicalTrial_41489> <http://ctro/data#hasAnalysisApproach> <http://ctro/data#IntentionToTreat>."
92996, AggregationMethod, 2511, 2523, "hazard ratio", "", "<http://ctro/data#AggregationMethod_41649> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://ctro/data#AggregationMethod>. <http://ctro/data#Endpoint_41647> <http://ctro/data#hasAggregationMethod> <http://ctro/data#AggregationMethod_41649>."
92997, AggregationMethod, 2526, 2528, "HR", "", 
75, ResultMeasuredValue, 2534, 2540, "0 . 54", "", "<http://ctro/data#Outcome_41652> <http://ctro/data#hasResultMeasuredValue> \"0 . 54\"."
76, ConfIntervalResValue, 2543, 2566, "95 % CI 0 . 30 - 0 . 90", "", "<http://ctro/data#Outcome_41652> <http://ctro/data#hasConfIntervalResValue> \"95 % CI 0 . 30 - 0 . 90\"."
77, PValueResValue, 2569, 2580, "P = 0 . 026", "", "<http://ctro/data#Outcome_41652> <http://ctro/data#hasPValueResValue> \"P = 0 . 026\"."
78, EndPointDescription, 2605, 2626, "cardiovascular events", "", 
66, Metformin, 2660, 2669, "metformin", "", 
63, Glipizide, 2686, 2695, "glipizide", "", 
65079, EndPointDescription, 2702, 2722, "secondary end points", "", 
79, EndPointDescription, 2727, 2741, "adverse events", "", 
65078, ObservedResult, 2742, 2797, "were not significantly different between the two groups", "", 
82, ConclusionComment, 2814, 2965, "Treatment with metformin for 3 years substantially reduced major cardiovascular events in a median follow - up of 5 . 0 years compared with glipizide .", "", "<http://ctro/data#ClinicalTrial_41489> <http://ctro/data#hasConclusionComment> \"Treatment with metformin for 3 years substantially reduced major cardiovascular events in a median follow - up of 5 . 0 years compared with glipizide .\"."
67, Metformin, 2829, 2838, "metformin", "", 
81, Duration, 2843, 2850, "3 years", "", 
154, Duration, 2928, 2939, "5 . 0 years", "", 
64, Glipizide, 2954, 2963, "glipizide", "", 
83, ConclusionComment, 2966, 3081, "Our results indicated a potential benefit of metformin therapy on cardiovascular outcomes in high - risk patients .", "", "<http://ctro/data#ClinicalTrial_41489> <http://ctro/data#hasConclusionComment> \"Our results indicated a potential benefit of metformin therapy on cardiovascular outcomes in high - risk patients .\"."
68, Metformin, 3011, 3020, "metformin", "", 
84, PMID, 3138, 3146, "23230096", "", "<http://ctro/data#Publication_41482> <http://ctro/data#hasPMID> \"23230096\"."
